Literature DB >> 7668897

Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion.

L C Tetlow1, D E Woolley.   

Abstract

OBJECTIVE: To determine the distribution, activation, and tryptase/chymase phenotype of mast cells (MCs) in the rheumatoid lesion.
METHODS: MC tryptase and chymase were studied by immunohistochemistry using monoclonal antibodies and examination by brightfield, interference, and fluorescent microscopy. Thirty four specimens of cartilage-pannus junction and 26 specimens of rheumatoid synovium, all derived from knee surgery, were examined.
RESULTS: MCs were identified in all specimens examined, but their distribution and local concentrations varied, both within and between specimens. As a proportion of total synovial cells, there were more MCs in fibrous synovial tissues than in those with active inflammatory cell infiltrations; MCs usually showed a peripheral distribution around lymphocytic/mononuclear cell infiltrations. Most cartilage-pannus specimens demonstrated local concentrations of MCs at, or close to, sites of cartilage erosion, a significant proportion of which showed extracellular tryptase indicative of MC degranulation. MC degranulation was often associated with localised oedema and disruption of the stromal matrix. Two MC phenotypes were identified: one population contained tryptase alone (MCT) whilst another contained both tryptase and chymase (MCTC). The ratio MCT:MCTC approximated 8:1.
CONCLUSIONS: This histological study demonstrated that local concentrations of MCs and their activation/degranulation are commonly observed in the rheumatoid lesion, and especially at sites of cartilage erosion. Such observations add weight to the concept that MCs contribute to the processes of inflammation, matrix degradation and tissue remodelling.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7668897      PMCID: PMC1009933          DOI: 10.1136/ard.54.7.549

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  28 in total

1.  The microscopic structure of normal human synovial tissue.

Authors:  C W CASTOR
Journal:  Arthritis Rheum       Date:  1960-04

2.  Cellular and extracellular changes following mast-cell secretion in avascular rat mesentery. An electron-microscopic study.

Authors:  K Norrby; S Eneström
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

3.  Mast cell products stimulate collagenase and prostaglandin E production by cultures of adherent rheumatoid synovial cells.

Authors:  J R Yoffe; D J Taylor; D E Wooley
Journal:  Biochem Biophys Res Commun       Date:  1984-07-18       Impact factor: 3.575

4.  Phagocytosis of mast cell granules by cultured fibroblasts.

Authors:  P V Subba Rao; M M Friedman; F M Atkins; D D Metcalfe
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

5.  Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases.

Authors:  H P Godfrey; C Ilardi; W Engber; F M Graziano
Journal:  Arthritis Rheum       Date:  1984-08

6.  Histamine stimulates prostaglandin E production by rheumatoid synovial cells and human articular chondrocytes in culture.

Authors:  D J Taylor; J R Yoffe; D M Brown; D E Woolley
Journal:  Arthritis Rheum       Date:  1986-02

7.  Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer.

Authors:  L B Schwartz; T R Bradford
Journal:  J Biol Chem       Date:  1986-06-05       Impact factor: 5.157

8.  Mast-cell products and heparin stimulate the production of mononuclear-cell factor by cultured human monocyte/macrophages.

Authors:  J R Yoffe; D J Taylor; D E Woolley
Journal:  Biochem J       Date:  1985-08-15       Impact factor: 3.857

9.  Collagenase at sites of cartilage erosion in the rheumatoid joint.

Authors:  D E Woolley; M J Crossley; J M Evanson
Journal:  Arthritis Rheum       Date:  1977 Jul-Aug

10.  Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.

Authors:  J M Dayer; B Beutler; A Cerami
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  30 in total

1.  Analysis of the cell infiltrate and expression of matrix metalloproteinases and granzyme B in paired synovial biopsy specimens from the cartilage-pannus junction in patients with RA.

Authors:  T J Smeets; M C Kraan; S Galjaard; P P Youssef; M D Smith; P P Tak
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

2.  Functional KCa3.1 K+ channels are required for human lung mast cell migration.

Authors:  G Cruse; S M Duffy; C E Brightling; P Bradding
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

3.  Eosinophils are an insignificant cellular component of rheumatoid synovium in patients with late stage disease: comparative distributions with mast cells and macrophages.

Authors:  L C Tetlow; D E Woolley
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

4.  Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis.

Authors:  A Juurikivi; C Sandler; K A Lindstedt; P T Kovanen; T Juutilainen; M J Leskinen; T Mäki; K K Eklund
Journal:  Ann Rheum Dis       Date:  2005-08       Impact factor: 19.103

Review 5.  Mast cells in the rheumatoid lesion--ringleaders or innocent bystanders?

Authors:  D E Wooley
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

6.  Mast cell-restricted, tetramer-forming tryptases induce aggrecanolysis in articular cartilage by activating matrix metalloproteinase-3 and -13 zymogens.

Authors:  Natalia J Magarinos; Katherine J Bryant; Amanda J Fosang; Roberto Adachi; Richard L Stevens; H Patrick McNeil
Journal:  J Immunol       Date:  2013-06-24       Impact factor: 5.422

7.  Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes.

Authors:  Kichul Shin; Peter A Nigrovic; James Crish; Eric Boilard; H Patrick McNeil; Katherine S Larabee; Roberto Adachi; Michael F Gurish; Reuben Gobezie; Richard L Stevens; David M Lee
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

8.  Mast cells as a target in the treatment of rheumatoid arthritis.

Authors:  O Bakharevski; P F Ryan
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

9.  Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis.

Authors:  T J M Smeets; E C Barg; M C Kraan; M D Smith; F C Breedveld; P P Tak
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

10.  Polyphenol-rich pomegranate fruit extract (POMx) suppresses PMACI-induced expression of pro-inflammatory cytokines by inhibiting the activation of MAP Kinases and NF-kappaB in human KU812 cells.

Authors:  Zafar Rasheed; Nahid Akhtar; Arivarasu N Anbazhagan; Sangeetha Ramamurthy; Meenakshi Shukla; Tariq M Haqqi
Journal:  J Inflamm (Lond)       Date:  2009-01-08       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.